Contact UsInvestorsCareersScienceContact Us
Investor Relations

FINANCIAL INFORMATION

2024-2025

Unaudited Results – Quarter ended September 30, 2024

AGM held on August 28, 2024 – Proceedings

Unaudited Results – Quarter ended June 30, 2024

2023-2024

Annual Report 2023 – 24

Annual Return 2023-24

Audited Results – Year ended March 31, 2024

Unaudited Results – Quarter ended December 31, 2023

Unaudited Results – Quarter ended September 30, 2023

AGM held on August 18, 2023 – Proceedings

Unaudited Results – Quarter ended June 30, 2023

2022-2023

AGM held on August 18, 2023 – Proceedings

Annual Report 2022 – 23

Annual Return 2022 – 23

Audited Results – Year ended March 31, 2023

Quarter Ended December 31, 2022

Quarter Ended September 30, 2022

AGM held on August 26, 2022 – Proceedings

Quarter ended June 30, 2022

2021-2022

Annual Report 2021 – 22

Annual Return 2021 – 22

Audited Results- Year ended March 31, 2022

Quarter ended December 31, 2021

Quarter ended September 30, 2021

Quarter ended June 30, 2021

2020-2021

AGM held on August 19, 2021 – Proceedings

Annual Report 2020-21

Annual Report 2020-21 (Interactive Mode)

Annual Return 2020-21

Audited Results – Year ended March 31, 2021

Quarter ended December 31, 2020

Quarter ended September 30, 2020.

Quarter ended June 30, 2020

2019-2020

Annual Return 2019-20.​​​​​​​

AGM held on September 4, 2020 – Proceedings

Annual Report 2019 – 20

Audited Results – Year ended March 31, 2020.

Quarter ended December 31, 2019

Quarter ended September 30, 2019.

Quarter ended June 30, 2019

2018-2019

Annual Report 2018 – 19

Audited Results – Year ended March 31, 2019.

Quarter ended December 31, 2018

Quarter ended September 30, 2018

Quarter ended June 30, 2018

2017-2018

Annual Report 2017 – 18​​​​​​​

Audited Results – Year ended March 31, 2018.

Quarter ended December 31, 2017

Quarter ended September 30, 2017.

Quarter ended June 30, 2017.

2016-2017

Annual Report 2016 – 17​​​

Audited Results – Year ended March 31, 2017.

Quarter ended December 31, 2016

Quarter ended September 30, 2016.

Quarter ended June 30, 2016.

2015-2016

Annual Report 2015 - 2016

Audited Results - Year Ended March 31, 2016

Quarter ended December 31, 2015

Quarter ended September 30, 2015

Quarter ended June 30, 2015

2014-2015

Annual Report 2014 - 2015

Audited Results – Year Ended March 31, 2015

Quarter ended December 31, 2014

Quarter ended September 30, 2014

Quarter ended June 30, 2014

2013-2014

Annual Report 2013 - 2014

Audited Results – Year Ended March 31, 2014 

Quarter Ended December 31 2013 

Quarter Ended September 30 2013

Quarter Ended June 30 2013

2012-2013

Annual Report 2012 - 2013

Audited Results - Year Ended March 31 2013

Quarter Ended December 31 2012

Quarter Ended September 30 2012

Quarter Ended June 30 2012

2011-2012

Annual Report 2011 - 2012

Audited Results - Year Ended March 31 2012

Quarter Ended December 31 2011

Quarter Ended September 30 2011

Quarter Ended June 30 2011

 Archives2010Annual Report 2011Audited Results - 16 Months Ended March 31 20114th Quarter Ended November 30 20103rd Quarter Ended August 31 20102nd Quarter Ended May 31 20101st Quarter Ended February 28 20102009Annual Report 2008 - 20092008Annual Report 2007 - 20082007Annual Report 2006 - 20072006Annual Report 2005 - 20062005Annual Report 2004 - 2005Annual Results Nov 20053rd Quarter Ended August 20052nd Quarter Ended May 20051st Quarter Ended Feb 20052004Annual Report 2003 - 2004Annual Results Nov 20042nd Quarter Ended May 20041st Quarter Ended Feb 20042003Annual Report 2002 - 2003Annual Results Nov 20033rd Quarter Ended August 2003Half Yearly Report May 20031st Quarter Ended Feb 20032002Annual Report 2001 - 2002Annual Results Nov 2002Half Yearly Report May 20022001Annual Report 2000 - 20012000Annual Report 1999 - 2000​​​​​​​1999Annual Report 1998 - 1999
About UsOur PeopleOur Community EffortsOur ProductsInvestorsCareerMediaAdverse Event ReportingHealth Care ProfessionalsTerms of UsePrivacy PolicyContact UsCopyright © 2002- 2021 Pfizer Inc. All rights reserved.